Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 6, 1996, Pages 566-570

  Thomson, Alison H ^a   Daly, Margaret ^b   Knepil, Janusz ^a   Harden, Paul ^a   Symonds, Paul ^b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Haemodialysis; Laryngeal carcinoma; Methotrexate; Pharmacokinetics

Indexed keywords

FOLINIC ACID; METHOTREXATE;

AGED; ARTICLE; CASE REPORT; DRUG HALF LIFE; DRUG MONITORING; DRUG SAFETY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LARYNX CARCINOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CARCINOMA, SQUAMOUS CELL; FATAL OUTCOME; HUMANS; INFUSIONS, PARENTERAL; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; LARYNGEAL NEOPLASMS; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; PALLIATIVE CARE; RENAL DIALYSIS; TERMINAL CARE;

EID: 0029841979     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050528     Document Type: Article

References (20)

1. Bleyer WA (1978) The clinical pharmacology of methotrexate. New applications of an old drug. Cancer 41: 36
2. Capizzi RL, DeConti RC, Marsh JC, Bertino JR (1970) Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". Cancer Res 30: 1782
3. Dalla Vale F, Cochat P, Bouffet E, Frappaz D, Bigot P, Vial M, Glastre C, Floret D (1994) Intoxication aigue au methotrexate: interet del l'hemodialyse couplee à l'hemoperfusion sur charbon active. Ann Pediatr (Paris) 41: 60
4. Djerassi I, Ciesielka W, Kim JS (1977) Removal of methotrexate by filtration-adsorption using charcoal filters or by hemodialysis. Cancer Treat Rep 61: 751
5. Ellman MH, Hou S, Ginsberg D (1990) Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis. Arthritis Rheum 33: 1060
6. Gauthier E, Gimonet JF, Piedbois P, Rostoker G, Buisson C, Ben Maadi A, Samyn B, Messadi AA, Brun B, Feuilhade F (1990) Effectiveness of hemodialysis in a case of acute methotrexate intoxication. Presse Med 19: 2023
7. Grimes DJ, Bowles MR, Buttsworth JA, Thomson DB, Ravenscroft PJ, Nixon PF, Whiting RF, Pond SM (1990) Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma. Drug Safety 5: 447
8. Hande KR, Balow JE, Drake JC, Rosenberg SA, Chabner BA (1977) Methotrexate and hemodialysis. Ann Intern Med 87: 495
9. Howell SB, Blair HE, Uren J, Frei E (1978) Hemodialysis and enzymatic cleavage of methotrexate in man. Eur J Cancer 11: 787
10. Langleben A, Hollomby D, Hand R (1982) Case report: management of methotrexate toxicity in an anephric patient. Clin Invest Med 5: 129
11. Milano G, Thyss A, Renee N, Vallicioni J, Santini J, Schneider M, Demard F (1986) Altered pharmacokinetics and clinical consequences of low dose methotrexate plus cisplatin in the treatment of head and neck cancer. Eur J Cancer Clin Oncol 22: 843
12. Molina R, Fabian C, Cowley B (1987) Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency. Am J Med 82: 350
13. Montagne N, Milano G, Caldani C, Bracco J, Ayela P, Cassuto E, Thyss A, Schneider M (1989) Removal of methotrexate by haemodiafiltration. Cancer Chemother Pharmacol 24: 400
14. Relling MV, Stapleton FB, Ochs J, Jones DP, Meyer W, Wainer IW, Crom WR, McKay CP, Evans WE (1988) Removal of methotrexate, leucovorin and their metabolites by combined hemodialysis and hemoperfusion. Cancer 62: 884
15. Sauer H, Fuger K, Blumenstein M (1990) Modulation of cytotoxicity of cytostatic drugs by haemodialysis in vitro and in vivo. Cancer Treat Rev 17: 293
16. Thierry FX, Vernier I, Dueymes JM, Roche H, Canal P, Meeus F, Pourrat JP, Conte JJ (1989) Acute renal failure after high dose methotrexate therapy. Nephron 51: 416
17. Wan SH, Huffman DL, Azarnoff DL, Stephens R, Hoogstraten B (1974) Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 34: 3487
18. Winter ME (1994) Methotrexate. In: Koda-Kimble MA, Young LY (eds) Basic clinical pharmacokinetics. Applied Therapeutics, Vancouver p 266
19. Woods RL, Fox RM, Tattersall MHN (1981) Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation. BMJ 282: 600
20. Yokogi H, Yamasaki Y, Ishibe T (1993) M-VAC therapy in a patient with ureteral carcinoma accompanied by chronic renal failure. JPn J Cancer Chemother 20: 2405